Lactation Stage-Related Expression of Sialylated and Fucosylated Glycotopes of Human Milk α-1-Acid Glycoprotein

Magdalena Orczyk-Pawiłowicz

Lidia Hirnle

Marta Berghausen-Mazur

Iwona Kątnik-Prastowska

^{Department of Chemistry and Immunochemistry, Wrocław Medical University, Wrocław, Poland.}

^{1st Department and Clinic of Gynaecology and Obstetrics, Wrocław Medical University, Wrocław, Poland.}

^{Corresponding author.}

Address correspondence to:, Magdalena Orczyk-Pawiłowicz, PhD, Department of Chemistry and Immunochemistry, Wrocław Medical University, Bujwida 44a, 50-345 Wrocław,, Poland,
E-mail:Email: lp.corw.demu@zciwoliwap-kyzcro.aneladgam

Abstract

Background: Because terminal sugars of α-1-acid glycoprotein (AGP) are reported to be involved in anti-inflammatory and immunomodulatory processes, their expressions might have an influence on the proper function of immune system of newborns. Here, relative amounts of sialylated and fucosylated glycotopes on human milk AGP over normal lactation were investigated.

Materials and Methods: AGP concentration and relative amounts of its sialylated and fucosylated glycovariants were analyzed in early colostrum, colostrum, and transitional and mature milk samples of 127 healthy mothers by lectin–AGP enzyme-linked immunosorbent assay using α2,3- and α2,6-sialic acid and α1,2-, α1,3-, and α1,6-fucose specific biotinylated Maackia amurensis, Sambucus nigra, Ulex europaeus, Tetragonolobus purpureus, and Lens culinaris lectins, respectively.

Results: AGP concentration in human milk was about 30 times lower than in plasma of lactating mothers and decreased gradually over lactation. Milk AGP showed significantly higher expression of sialylated and fucosylated glycotopes in comparison with those of plasma AGP. Milk AGP glycovariants containing α2,6-sialylated and α1,6- and α1,2-fucosylated glycotopes showed the highest relative amounts in early colostrums. With progression of lactation, the expressions of glycotopes α1,2-fucosylated decreased starting from Day 4 and those of α2,6-sialylated and α1,6-fucosylated from Day 8 of lactation, whereas the level of α2,3-sialyl-glycotope was almost constant over 45 days of lactation. In contrast, the expression of α1,3-linked fucose on AGP was low in colostrums and significantly higher in transitional and mature milk.

Conclusions: The relative amounts of sialylated and fucosylated glycovariants of human hindmilk AGP significantly varied between Days 2 and 45 of normal lactation.

Abstract

References

1. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 2005;25:37–58 [[PubMed]
2. Froehlich JW, Dodds ED, Barboza M, et al. Glycoprotein expression in human milk during lactation. J Agric Food Chem 2010;58:6440–6448
3. Kobata A. Structures and application of oligosaccharides in human milk. Proc Jpn Acad Ser B Phys Biol Sci 2010;86:731–747
4. Bode L. Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology 2012;22:1147–1162
5. D'Alessandro A, Scaloni A, Zolla L. Human milk proteins: An interactomics and updated functional overview. J Proteome Res 2010;9:3339–3373 [[PubMed]
6. Gao X, McMahon RJ, Woo JG, et al. Temporal changes in milk proteomes reveal developing milk functions. J Proteome Res 2012;11:3897–3907 [[PubMed]
7. Barboza M, Pinzon J, Wickramasinghe S, et al. Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteria-host interactions. Mol Cell Proteomics 2012;11:M111.015248.
8. Landberg E, Huang Y, Strömqvist M, et al. Changes in glycosylation of human bile-salt-stimulated lipase during lactation. Arch Biochem Biophys 2000;377:246–254 [[PubMed]
9. Ceciliani F, Pocacqua V. The acute phase protein α1-acid glycoprotein: A model for altered glycosylation during diseases. Curr Prot Pept Sci 2007;8:91–108 [[PubMed]
10. Gendler SJ, Dermer GB, Silverman LM, et al. Synthesis of alpha 1-antichymotrypsin and alpha 1-acid glycoprotein by human breast epithelial cells. Cancer Res 1982;42:4567–1573 [[PubMed]
11. Fournier T, Medjoubi NN, Porquet D. Alpha 1-acid glycoprotein. Biochim Biophys Acta 2000;1482:157–171 [[PubMed]
12. Ceciliani F, Pocacqua V, Provasi E, et al. Identification of the bovine α1-acid glycoprotein in colostrum and milk. Vet Res 2005;36:735–746 [[PubMed]
13. Shiyan SD, Bovin NV. Carbohydrate composition and immunomodulatory activity of different glycoforms of α1-acid glycoprotein. Glycoconj J 1997;14:631–638 [[PubMed]
14. Orczyk-Pawiłowicz M, Hirnle L, Kątnik-Prastowska I. Alterations of N-glycan branching and expression of sialic acid on amniotic fluid alpha-1-acid glycoprotein derived from second and third trimesters of normal and prolonged pregnancies. Clin Chim Acta 2006;367:86–92 [[PubMed]
15. Orczyk-Pawiłowicz M, Hirnle L, Kątnik-Prastowska I. The expression of fucose isoforms of amniotic and plasma alpha-1-acid glycoprotein derived from 2nd and 3rd trimester normal pregnancies. Clin Biochem 2009;42:1517–1523 [[PubMed]
16. Orczyk-Pawiłowicz M, Hirnle L, Kątnik-Prastowska I. High expression of α1,2- and α1,6-linked fucoses on amniotic AGP as a biomarker of fetal postmaturity risk. J Immunoassay Immunochem 2011;32:103–113 [[PubMed]
17. Van Dijk W, Brinkman-Van der Linden ECM, Havenaar EC. Glycosylation of alpha₁-acid glycoprotein (orosomucoid) in health and disease: Occurrence, regulation and possible functional implications. Trends Glycosci Glycotechnol 1998;10:235–245 [PubMed]
18. Maeda H, Nishi K, Mori I. Facilitating effects of alpha-1 acid glycoprotein on the passage of erythrocytes through the membrane-filter. Life Sci 1980;27:157–161 [[PubMed]
19. Athamna A, Kramer MR, Kahane I. Adherence of Mycoplasma pneumoniae to human alveolar macrophages. FEMS Immunol Med Microbiol 1996;15:135–141 [[PubMed]
20. Orczyk-Pawiłowicz M, Kątnik-Prastowska I. Terminal monosaccharide expression on amniotic glycoproteins as biomarkers of fetus maturity. Biochem Soc Trans 2011;39:344–348 [[PubMed]
21. Burvenich C, Van Merris V, Mehrzad J, et al. Severity of E. coli mastitis is mainly determined by cow factors. Vet Res 2003;34:521–564 [[PubMed]
22. Tilg H, Vannier E, Vachino G, et al. Antiinflammatory properties of hepatic acute phase proteins: Preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med 1993;178:1629–2636
23. Wu AM, Lisowska E, Duk M, et al. Lectins as tools in glycoconjugate research. Glycoconj J 2009;26:899–913 [[PubMed]
24. Yan L, Wilkins PP, Alvarez-Manilla G, et al. Immobilized Lotus tetragonolobus agglutinin binds oligosaccharides containing the Le^determinant. Glycoconj J 1997;14:45–55 [[PubMed]
25. Kątnik I, Jadach J, Krotkiewski H, et al. Investigating the glycosylation of normal and ovarian cancer haptoglobins using digoxigenin-labeled lectins. Glycosyl Dis 1994;1:97–104 [PubMed]
26. Lönnerdal B. Bioactive proteins in breast milk. J Paediatr Child Health 2013;49:1–7 [[PubMed]
27. Nwosu CC, Aldredge DL, Lee H, et al. Comparison of the human and bovine milk N-glycome via high-performance microfluidic chip liquid chromatography and tandem mass spectrometry. J Proteome Res 2012;11:2912–2924
28. Wang B, Brand-Miller J. The role and potential of sialic acid in human nutrition. Eur J Clin Nutr 2003;57:1351–1369 [[PubMed]
29. Carlson SE. N-Acetylneuraminic acid concentrations in human milk oligosaccharides and glycoproteins during lactation. Am J Clin Nutr 1985;41:720–726 [[PubMed]
30. Chaturvedi P, Warren CD, Altaye M, et al. Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 2001;11:365–372 [[PubMed]
31. De Leoz ML, Gaerlan SC, Strum JS, et al. Lacto-N-tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm. J Proteome Res 2012;11:4662–4672
32. Groër M, Davis M, Casey K, et al. Neuroendocrine and immune relationships in postpartum fatigue. MCN Am J Matern Child Nurs 2005;30:133–138 [[PubMed]
33. Zivkovic AM, German JB, Lebrilla CB, et al. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci U S A 2011;108:4653–4658
34. Erbağci AB, Cekmen MB, Balat O, et al. Persistency of high proinflammatory cytokine levels from colostrum to mature milk in preeclampsia. Clin Biochem 2005;38:712–716 [[PubMed]
35. Ostrom KM. A review of the hormone prolactin during lactation. Prog Food Nutr Sci 1990;14:1–43 [[PubMed]
36. Goldblum RM, Hilton S. Amniotic fluid and the fetal mucosal immune system. In: Ogra PL, editor; , Mestecky J, editor; , Lamm ME, et al., eds. Mucosal Immunology, 2nd ed. London, Academic Press, 1999:1555–1564 [PubMed]
37. Garofalo RP, Goldman AS. Cytokines, chemokines, and colony-stimulating factors in human milk: The 1997 update. Biol Neonate 1998;74:134–142 [[PubMed]
38. Goldman AS. Evolution of the mammary gland defense system and the ontogeny of the immune system. J Mammary Gland Biol Neoplasia 2002;7:277–289 [[PubMed]
39. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 2005;25:37–58 [[PubMed]
40. Newburg DS. Glycobiology of human milk. Biochemistry (Moscow) 2013;78:771–785 [[PubMed]
41. Schauer R. Sialic acids as regulators of molecular and cellular interactions. Curr Opin Struct Biol 2009;19:507–514 [[PubMed]